In addition to treatment related factors, inactivity and malnutrition, sarcopenia among cancer survivors could also be attributed to loss of α-motoneuron, increased interleukin-6 (IL-6) and blunted secretion of growth hormone [34,35]. This evidence concerns the gene GH1 and cancer.